Chemical and biological properties of the carcinostatic protein fraction of Escherichia coli. 1978

S Namiki, and K Igarashi, and T Watanabe

A carcinostatic protein fraction (EPF) was separated from Escherichia coli 055 cells by the following procedure: E. coli 055 cells were suspended in distilled water, and extracted by repeater freezing and thawing. The extracts were centrifuged and the supernatant was treated with 1N acetic acid (pH 4.5). Acid precipitate collected by centrifugation was dissolved in alkaline water (pH 8 to 9) and subjected to gel filtration on Sephadex G-200 column. The high molecular weight fraction obtained by gel filtration was collected, freeze-dried, and designated as EPF. EPF was composed of approximately 74.5% of protein, 20.4% of lipid, and a small amount of polysaccharide. The isoelectric point of EPF was pH 5.2 +/- 0.A and the ultraviolet spectrum showed absorption maximum at 278 nm (E1%1cm 4.30) in 0.01M Tris-HCl (pH 7.8) buffer. The antitumor experiment with EPF demonstrated that the daily injection of EPF in a dose of 10 microgram/mouse inhibited sarcoma-180 ascites in 90% of the treated animals and the dose of 100 micrograms/mouse brought about 100% inhibition. In the contact test using C3H2K and C3HW2K cells, 200 micrograms/ml of EPF exhibited about 40% cell destruction. In the ihhibition test of 14C-phenylalanine incorporation into intact sarcoma-180 cells, EPF exhibited 60.5% inhibition at the concentration of 275 micrograms/ml. In contrast, EPF did not show any inhibition of the incorporation of 3H-uridine or 3H-thymidine.

UI MeSH Term Description Entries
D007526 Isoelectric Point The pH in solutions of proteins and related compounds at which the dipolar ions are at a maximum. Isoelectric Points,Point, Isoelectric,Points, Isoelectric
D007928 Lethal Dose 50 The dose amount of poisonous or toxic substance or dose of ionizing radiation required to kill 50% of the tested population. LD50,Dose 50, Lethal
D011135 Polysaccharides, Bacterial Polysaccharides found in bacteria and in capsules thereof. Bacterial Polysaccharides
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D012510 Sarcoma 180 An experimental sarcoma of mice. Sarcoma 180, Crocker,Crocker Sarcoma 180
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

S Namiki, and K Igarashi, and T Watanabe
December 1971, Veterinariia,
S Namiki, and K Igarashi, and T Watanabe
August 1967, Biochemistry,
S Namiki, and K Igarashi, and T Watanabe
December 1975, The science reports of the research institutes, Tohoku University. Ser. C, Medicine. Tohoku Daigaku,
S Namiki, and K Igarashi, and T Watanabe
September 1967, Biulleten' eksperimental'noi biologii i meditsiny,
S Namiki, and K Igarashi, and T Watanabe
November 1977, European journal of biochemistry,
S Namiki, and K Igarashi, and T Watanabe
July 1971, The Journal of biological chemistry,
S Namiki, and K Igarashi, and T Watanabe
January 1970, Biochemistry,
S Namiki, and K Igarashi, and T Watanabe
April 2005, Journal of medical microbiology,
S Namiki, and K Igarashi, and T Watanabe
October 1963, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
S Namiki, and K Igarashi, and T Watanabe
January 1973, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Copied contents to your clipboard!